REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 24 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,999,000 | -9.0% | 26,199,000 | +8.3% | 0.67% | -3.6% |
| Q3 2022 | $26,377,000 | +112.2% | 24,199,000 | +61.3% | 0.70% | +31.8% |
| Q2 2022 | $12,432,000 | -73.8% | 15,000,000 | -69.7% | 0.53% | -63.4% |
| Q1 2022 | $47,535,000 | +67.4% | 49,500,000 | +54.7% | 1.45% | +3.1% |
| Q4 2021 | $28,400,000 | – | 32,000,000 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |